Why would free content be differentially accessed across versions of it, and across publications? A dive into PLoS data leads to a potentially reassuring answer.
When you think through all the effects stealing traffic has on online publishing businesses, PubMed Central’s competitive presence looms large — whether you sell subscriptions, ads, or APCs.
More information emerges about PubMed Central, its processes, its relationship with eLife, and its role as a technology provider. Overall, it looks like certain OA friends get special treatment, and the processes you think occur are often short-circuited and may not even be tracked.
Last week, PubMed Central became the primary and sole publisher of eLife content, putting its competition with publishers, its manipulation of PubMed indexing criteria, its competition with publishing technology companies, and its clear OA bias into stark relief.
Articles deposited into PubMed Central responsible for drawing readers from journal site, a study finds.